Chronic cough, defined as a cough persisting beyond eight weeks, presents a diagnostic challenge to clinicians due to its multi-factorial etiology. It can significantly impair quality of life, causing physical, social, and psychological distress. This article provides a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
The initial evaluation of a patient with chronic cough should include a detailed history and physical examination to identify common causes such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). Diagnostic tests should be guided by the patient's history and physical examination. In cases where common causes are ruled out, more extensive testing may be required to identify less common causes such as non-asthmatic eosinophilic bronchitis, bronchiectasis, or neoplasms.
Treatment should primarily target the underlying cause of the cough. For example, proton pump inhibitors may be prescribed for GERD, inhaled corticosteroids for asthma, and antihistamines for UACS. If the cough persists despite treatment, it may be classified as a refractory chronic cough. In these cases, a multidisciplinary approach involving pulmonologists, gastroenterologists, and otolaryngologists may be beneficial. Non-pharmacological interventions such as speech and language therapy can also be considered.
Recent research has highlighted the role of neuronal hypersensitivity in the pathogenesis of chronic cough. New therapies targeting neuronal pathways such as P2X3 receptor antagonists and transient receptor potential (TRP) channel modulators are currently under investigation and may offer new hope for patients with refractory chronic cough.
In conclusion, chronic cough is a complex medical condition that requires a thorough diagnostic evaluation and a targeted treatment approach. The management of refractory cases can be challenging, but emerging therapies offer promising avenues for future treatment. Continued research and collaboration across specialties are essential for advancing our understanding and management of this debilitating condition.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation